See All Slides - tctmd.com

Slides

Presentation TCT 2013

Prognostic Impact of Functional MR in Heart Failure: Association or Causation?

Presenter: Francesco Grigioni

October 28, 2013

Presentation TCT 2013

TCT-130. Marrow Stromal Cell Based Transcatheter Aortic Valve Implantation – Experiences in a Preclinical Animal Model

Presenter: Maximilian Emmert

October 28, 2013

Presentation TCT 2013

Latest Data from SCAAR and SWEDEHEART: Can a Nationwide Registry Tease Out Important Findings Hidden from Randomized Trials?

Presenter: Bo Lagerqvist

October 28, 2013

Presentation TCT 2013

Case Presentation: Patient Introduction and Diagnostic Imaging

Presenter: Junjie Zhang

October 28, 2013

Presentation TCT 2013

How Should OCT Be Used in a Busy Cath Lab to Improve Clinical Outcomes?

Presenter: Daniel Chamie

October 28, 2013

Presentation TCT 2013

Do I Really Need Bioresorbable Scaffolds in the United States?

Presenter: Gregg Stone

October 28, 2013

Presentation TCT 2013

DISCOVER: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Presenter: Joachim Schofer

October 28, 2013

Presentation TCT 2013

Selecting the Best Antiplatelet Strategy for ACS and Stable CAD

Presenter: Oscar Mendiz

October 28, 2013

Presentation TCT 2013

Niche Role, Given Their Less Forgiving Nature, Greater Cost, and Lack of Proven Clinical Benefit!

Presenter: David Hildick-Smith

October 27, 2013

Presentation TCT 2013

Pro!

Presenter: Paul Sobotka

October 27, 2013

Advertisement

Slides

Prognostic Impact of Functional MR in Heart Failure: Association or Causation?

TCT-130. Marrow Stromal Cell Based Transcatheter Aortic Valve Implantation – Experiences in a Preclinical Animal Model

Latest Data from SCAAR and SWEDEHEART: Can a Nationwide Registry Tease Out Important Findings Hidden from Randomized Trials?

Case Presentation: Patient Introduction and Diagnostic Imaging

How Should OCT Be Used in a Busy Cath Lab to Improve Clinical Outcomes?

Do I Really Need Bioresorbable Scaffolds in the United States?

DISCOVER: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Selecting the Best Antiplatelet Strategy for ACS and Stable CAD

Niche Role, Given Their Less Forgiving Nature, Greater Cost, and Lack of Proven Clinical Benefit!

Pro!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content